Melanoma
News
Melanoma screening: Consensus statement offers greater clarity
Overall, the panelists agreed that a risk-stratified approach is likely the most appropriate strategy for melanoma screening and follow-up and...
News
Pembrolizumab before and after melanoma surgery boosts outcomes
"It's not just what you give; it's when you give it," said lead author Sapna Patel, MD, in a press release.
News
Expert discusses pros, cons of molecular tests for melanoma
Next generation sequencing allows for the generation of millions of sequencing reads that are aligned to a standard human genome, and likely...
News
More than 97K new cutaneous melanoma diagnoses expected in 2023
More than 1.3 million people in the United States live with cutaneous melanoma, and the overall 5-year survival is 93.7%.
News
Dermoscopy, other modalities for improving melanoma diagnoses reviewed
The learning curve for dermoscopy is steep, he added, and whether the technique should be considered a first-line tool or as a supplement to other...
Opinion
Oncologists may be too quick to refer patients to palliative care
Integrating palliative care into routine cancer care need not always require a specialty palliative care nurse.
News
Melanoma mortality rates fell in 2010s as new therapies took hold
Immunotherapy and targeted therapy appear to be paying dividends, new study finds.
News
Who’s more likely to develop a second primary melanoma?
"High numbers of nevi and high genetic predisposition were more strongly associated with second [rather] than first primary melanomas."
Conference Coverage
Latinx and melanoma: Barriers and opportunities
A qualitative study in California reveals challenges and attitudes that could be addressed with new melanoma outreach and prevention strategies....
Conference Coverage
Stage 3 melanoma attacked with immunotherapy and a virus-like particle
Phase 2 trial achieves some success, and responders had infiltrate of plasmacytoid dendritic cells.
